United States Infusion Bags Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

Read more about this report - Request a Free Sample

United States Infusion Bags Market Overview

The United States Infusion Bags Market comprises a broad range of sterile medical containers used for the intravenous administration of fluids, electrolytes, parenteral nutrition, blood and blood components, dialysis solutions, and injectable medications. The market includes intravenous (IV) solution bags, total parenteral nutrition (TPN) bags, blood bags, dialysis solution bags, specialty infusion bags, and associated fluid delivery systems manufactured using PVC and non-PVC materials. Infusion bags play a vital role in fluid management, drug delivery, nutritional support, and transfusion therapy across hospitals, ambulatory surgical centers, specialty clinics, and home healthcare settings. The market was valued at USD 84.69 Million in 2025, driven by the rising prevalence of chronic diseases requiring intravenous therapy, increasing surgical procedures and hospital admissions, growing demand for home-based infusion care, expanding adoption of DEHP-free and non-PVC infusion bags, supportive healthcare investments across United States, and continuous advancements in sterile manufacturing technologies, material innovation, and infusion safety systems.

United States Infusion Bags Market Growth Analysis and Key Influencers

United States Infusion Bags Market Dynamics

The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.

United States Infusion Bags Market Growth Drivers

Rising Chronic Disease Burden and Expanding Intravenous Care Accelerate Infusion Bag Demand

United States's growing burden of chronic diseases, ageing demographics, and increasing surgical procedures continue to strengthen demand for infusion bags used in hydration, chemotherapy, parenteral nutrition, dialysis, and biologic administration. As per Pérez-Granda et al., 2025, safe vascular access and intravenous therapy remain central to modern hospital care. Recent product innovation has also reinforced market momentum; in 2025, B. Braun expanded investments in infusion technologies and manufacturing while strengthening its IV solutions portfolio. Stable public healthcare expenditure across United States and improving capital investment in hospital infrastructure further support procurement despite persistent inflationary pressures.

United States Infusion Bags Market Restraints

Raw Material Price Volatility and Stringent Regulatory Compliance Increase Manufacturing Costs

The United States infusion bags market faces persistent challenges from fluctuating prices of medical-grade polymers, resins, and packaging materials, coupled with stringent regulatory and quality compliance requirements that increase manufacturing costs. According to the U.S. Food and Drug Administration (FDA), 2025, manufacturers continue to strengthen quality systems and domestic production to improve the resilience of the intravenous fluid supply chain. During 2025, leading companies expanded manufacturing capacity to mitigate supply risks; however, higher labor costs, capital-intensive production upgrades, and continued inflationary pressures remain significant constraints. From a macroeconomic perspective, elevated interest rates, rising operating expenses, and ongoing raw material price volatility continue to moderate investment returns and compress profit margins despite sustained demand for infusion therapies.

United States Infusion Bags Market Opportunities

Sustainable Non-PVC Technologies and Home Infusion Expand Long-Term Growth Opportunities

The transition toward environmentally sustainable infusion products and expanding home-based care presents significant opportunities for manufacturers across United States. According to B. Braun, 2025, healthcare providers are increasingly adopting IV containers manufactured without DEHP or PVC to improve patient safety, drug compatibility, and environmental sustainability. Simultaneously, the rapid expansion of home infusion services, outpatient infusion centers, and biologic therapies is driving demand for advanced infusion systems throughout the United States and Canada. During 2025, manufacturers continued investing in domestic production capacity and innovative non-PVC infusion technologies to strengthen supply resilience. From a macroeconomic perspective, sustained public and private healthcare investment, favorable reshoring initiatives, and increasing capital expenditure in medical device manufacturing are reinforcing long-term market growth despite persistent raw material cost inflation and elevated financing expenses.

United States Infusion Bags Market Trends

Rapid Transition Toward Non-PVC and DEHP-Free Infusion Bags Emerges as the Defining Market Trend

The most significant trend shaping the United States infusion bags market is the rapid transition from conventional PVC infusion bags to non-PVC, DEHP-free alternatives, driven by stringent medical device regulations, heightened patient safety requirements, and increasing adoption of sustainable healthcare practices. According to B. Braun, 2025, healthcare providers are increasingly adopting infusion containers manufactured without PVC or DEHP to improve drug compatibility, medication safety, and environmental performance. During 2025, manufacturers including Baxter International, ICU Medical, and B. Braun continued expanding domestic production capacity and advancing multilayer polymer technologies to strengthen supply resilience and meet rising regional demand. From a macroeconomic perspective, continued investment in domestic medical manufacturing, healthcare infrastructure modernization, and supply-chain resilience initiatives are attracting strategic capital despite elevated raw material costs and higher financing expenses, reinforcing long-term market growth.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Read more about this report - Request a Free Sample

United States Infusion Bags Market Share

Intravenous Fluid Therapy is Likely to Dominate the United States Infusion Bags Market by Application

Intravenous fluid therapy represents the largest application segment in the United States infusion bags market owing to its indispensable role in managing dehydration, electrolyte imbalance, perioperative care, sepsis, trauma, oncology, and critical care across hospitals, ambulatory surgical centers, and home healthcare settings. According to the U.S. Food and Drug Administration (FDA), 2025, strengthening the resilience of the intravenous fluid supply chain and expanding domestic manufacturing remain priorities to ensure the availability of essential IV solutions. During 2025, Baxter International and ICU Medical continued expanding manufacturing capacity and reinforcing their intravenous solutions portfolios to address growing clinical demand across the region. From a macroeconomic perspective, sustained healthcare expenditure, an ageing population, increasing chronic disease prevalence, and continued investment in domestic medical manufacturing are supporting long-term demand for intravenous fluid therapy despite persistent inflationary pressures and supply chain challenges.

Leading Players in the United States Infusion Bags Market

United States Infusion Bags Market Segmentation

Key Questions Answered in the United States Infusion Bags Market Report

• What was the United States Infusion Bags market value in 2025?
• What is the United States Infusion Bags market forecast outlook for 2026-2035?
• What are the major factors aiding the United States Infusion Bags market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major United States Infusion Bags market trends?
• Which product type is expected to dominate the market segment?
• Which material is projected to lead the market segment?
• Which capacity is anticipated to drive the market segment?
• Which application is likely to dominate the market segment?
• Which end user is likely to dominate the market segment?
• Which distribution channel is expected to lead the market segment?
• Who are the key players involved in the United States Infusion Bags market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?